Human brainstem serotonin receptors: characterization and implications for subcortical myoclonus

Area of Science:

• Neuroscience
• Pharmacology
• Neurochemistry

Background:

• 5-hydroxy-L-tryptophan (L-5-HTP), a serotonin precursor, is being studied for myoclonic disorders.
• The precise mechanism of L-5-HTP in the human central nervous system (CNS) remains unclear.
• Understanding serotonin (5-HT) receptor interactions is crucial for L-5-HTP's therapeutic potential.

Purpose of the Study:

• To investigate the binding affinity and density of serotonin (5-HT) receptor subtypes in human brainstem and cortex.
• To determine the in vitro activity of L-5-HTP and 5-HT at various 5-HT receptor subtypes.
• To elucidate the mechanism of action of L-5-HTP in the context of myoclonic disorders.

Main Methods:

• In vitro measurement of 5-HT1 and 5-HT2 receptor subtype density and affinity in human brainstem and cortex.
• Competition binding studies using 5-HT and L-5-HTP against various 5-HT receptor subtypes.
• Analysis of receptor binding data to determine Bmax and affinity constants.

Main Results:

• In the cortex, 5-HT2A (low-affinity) and 5-HT1A receptors showed the highest density, while 5-HT1E/F and high-affinity 5-HT2A sites had low binding.
• In the brainstem, 5-HT uptake sites and 5-HT1D receptors were most prominent, with fewer 5-HT1E/F and 5-HT2A sites.
• L-5-HTP demonstrated >1,000-fold lower activity than 5-HT at tested receptors, suggesting conversion to 5-HT is necessary for receptor stimulation.

Conclusions:

• L-5-HTP likely stimulates CNS 5-HT receptors in humans only after being converted to 5-HT.
• The human brainstem exhibits a distinct 5-HT receptor profile, with abundant 5-HT1A sites and scarce 5-HT1D, 5-HT1E/F, and 5-HT2A sites.
• These findings have implications for understanding brainstem-mediated myoclonus and the efficacy of serotonergic drugs.